Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.8%

15 terminated/withdrawn out of 72 trials

Success Rate

71.7%

-14.8% vs industry average

Late-Stage Pipeline

3%

2 trials in Phase 3/4

Results Transparency

111%

42 of 38 completed trials have results

Key Signals

7 recruiting42 with results14 terminated

Enrollment Performance

Analytics

N/A
48(92.3%)
Phase 2
2(3.8%)
Phase 4
1(1.9%)
Phase 3
1(1.9%)
52Total
N/A(48)
Phase 2(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials
NCT03635424Not ApplicableActive Not Recruiting

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

Role: lead

NCT01675440Completed

Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

Role: lead

NCT06906926Not ApplicableRecruiting

Harmony TPV EMEA PMS

Role: lead

NCT03242642Not ApplicableRecruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Role: lead

NCT01534819Completed

ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

Role: lead

NCT05378347Not ApplicableRecruiting

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

Role: lead

NCT02701283Not ApplicableActive Not Recruiting

Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

Role: lead

NCT05149755Not ApplicableActive Not Recruiting

Evolut™ EXPAND TAVR II Pivotal Trial

Role: lead

NCT04433065Not ApplicableRecruiting

TTVR Early Feasibility Study

Role: lead

NCT04722250Not ApplicableActive Not Recruiting

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

Role: lead

NCT06777368Recruiting

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Role: lead

NCT02322840Not ApplicableActive Not Recruiting

Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System

Role: lead

NCT04091048Completed

Optimize PRO Study

Role: lead

NCT07321899Not ApplicableNot Yet Recruiting

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Role: lead

NCT05077774Not ApplicableActive Not Recruiting

Harmony TPV Post-Approval Study

Role: lead

NCT05496998Not ApplicableRecruiting

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

Role: lead

NCT04982588Not ApplicableActive Not Recruiting

Evolut PRO China Clinical Study

Role: lead

NCT01586910Not ApplicableActive Not Recruiting

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Role: lead

NCT03320252Active Not Recruiting

Endurant CHevAr New Indication Trial: ENCHANT

Role: lead

NCT03417011Completed

FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

Role: lead